STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific (TMO), reported multiple disposals of common stock on 08/28/2025 at a price of $489.74 per share. The Form 4 shows four separate disposition entries totaling 667.718 shares disposed (175.028 + 187.116 + 186.632 + 118.942) and remaining direct beneficial ownership reported in fractional amounts (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 across lines). The filing also reports indirect holdings of 1,174.88 shares through a 401(k) plan and 5.036 shares via a limited liability company, with a disclaimer of beneficial ownership for the LLC position.

Positive

  • Continued equity ownership shown via a TMO 401(k) holding of 1,174.88 shares
  • Disclosure of indirect ownership through a limited liability company (5.036 shares) with a clear disclaimer

Negative

  • Insider disposed of 667.718 shares across four reported transactions on 08/28/2025
  • Multiple disposal entries reduced direct share counts as shown by the reported post-transaction ownership lines

Insights

TL;DR: Multiple insider stock dispositions occurred on 08/28/2025 at $489.74, while the reporting person retains both direct and indirect holdings.

The report documents four discrete disposition transactions totaling 667.718 shares sold at $489.74 each. Post-transaction direct ownership is recorded on multiple lines as fractional share totals. Additionally, 1,174.88 shares are held in a TMO 401(k) and 5.036 shares are held indirectly via an LLC, with a disclaimer of beneficial ownership for the LLC stake. From an investor-data perspective, these are standard insider liquidity transactions without accompanying company operational or financial metrics in the filing.

TL;DR: The Form 4 discloses routine insider dispositions and stated indirect holdings; no governance events or role changes are reported.

The form indicates the reporting person is an Executive Vice President and lists multiple dispositions executed the same day under transaction code F. The filing clarifies indirect ownership categories (401(k) and an LLC) and includes a standard disclaimer regarding the LLC interest. There are no amendments, officer title changes, or joint filers noted. This disclosure meets Section 16 reporting requirements but does not signal governance actions.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lowery Frederick M.

(Last) (First) (Middle)
168 THIRD AVENUE

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/28/2025 F 175.028 D $489.74 14,860.0624 D
Common Stock 08/28/2025 F 187.116 D $489.74 14,672.9464 D
Common Stock 08/28/2025 F 186.632 D $489.74 14,486.3144 D
Common Stock 08/28/2025 F 118.942 D $489.74 14,367.3724 D
Common Stock 1,174.88(1) I by 401K
Common Stock 5.036 I by Limited Liability Company(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Between February 29, 2025 and August 28, 2025, the reporting person acquired 27.08 shares of TMO common stock under the TMO 401(k) plan.
2. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
/s/ Melodie T. Morin, Attorney-in-Fact for Frederick M. Lowery 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Frederick M. Lowery report on the Form 4 for TMO?

The Form 4 reports four dispositions of Thermo Fisher Scientific common stock on 08/28/2025 at $489.74 per share and shows remaining direct and indirect holdings.

How many shares were disposed by the insider on 08/28/2025?

The filing shows dispositions of 175.028, 187.116, 186.632, and 118.942 shares, totaling 667.718 shares.

Does the Form 4 show any indirect holdings for the reporting person?

Yes. The report lists 1,174.88 shares held via a TMO 401(k) plan and 5.036 shares indirectly held by a limited liability company, with a disclaimer of beneficial ownership for the LLC position.

What is the reporting person's role at Thermo Fisher Scientific?

The filing identifies the reporting person as an Executive Vice President of Thermo Fisher Scientific.

Was this Form 4 filed jointly by multiple reporting persons?

No. The form indicates it was filed by one reporting person.
Thermo Fishr Sci

NYSE:TMO

TMO Rankings

TMO Latest News

TMO Latest SEC Filings

TMO Stock Data

220.72B
375.07M
0.16%
91.87%
1.04%
Diagnostics & Research
Measuring & Controlling Devices, Nec
Link
United States
WALTHAM